Product image of Mometasonfuroat Aristo Pharma (Mometasone Furoate Ph. Eur.) supplied by GNH India

Mometasonfuroat Aristo Pharma

Active Ingredient:
Mometasone Furoate Ph. Eur.
Origin:
EU

Mometasonfuroat Aristo Pharma (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometasonfuroat Aristo Pharma, is a corticosteroid presented as a nasal spray for nasal administration. It is used to reduce inflammation in the nasal passages of patients with allergic rhinitis or nasal polyps. It is formulated according to the European Pharmacopoeia specifications and is intended for adult and adolescent patients.

GNH India supplies Mometasonfuroat Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Aristo Pharma Gmbh (Art 57)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate, a nasal corticosteroid, acts on inflammatory pathways of the nasal mucosa to relieve symptoms.

  • Allergic rhinitis: reduces nasal congestion, itching and sneezing by decreasing mucosal inflammation.
  • Nasal polyps: shrinks polyp size and improves nasal airflow through anti‑inflammatory action.
  • Seasonal allergic rhinitis: alleviates seasonal symptom flare‑ups by controlling nasal inflammation.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors in nasal epithelial cells, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction suppresses the production of pro‑inflammatory cytokines, chemokines and adhesion molecules, leading to reduced vascular permeability, edema and cellular infiltration in the nasal mucosa, thereby alleviating inflammatory symptoms.

Side Effects

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nasal irritation or burning sensation
  • Headache
  • Epistaxis (nosebleed)
  • Altered taste or throat irritation

Serious or Rare Side Effects

  • Nasal septal perforation
  • Severe allergic reaction (anaphylaxis)
  • Adrenal suppression with prolonged high‑dose use

Precautions & Warnings

When prescribing Mometasone furoate nasal spray, clinicians should consider several safety measures.

  • Assess for active nasal infection: avoid use until infection resolved.
  • Avoid in patients with known hypersensitivity to mometasone or formulation excipients.
  • Use the lowest effective dose: limit duration to recommended period.
  • Monitor for signs of adrenal suppression: especially with long‑term or high‑dose therapy.
  • Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone furoate nasal spray can interact with other medications, affecting its safety or efficacy.

Major Interactions (Avoid)

  • Concurrent systemic corticosteroids: increased risk of systemic glucocorticoid effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure.

Moderate Interactions (Monitor Closely)

  • Antihistamines: may increase local irritation.
  • Nasal decongestants: combined use can cause excessive dryness.
  • Immunosuppressants: monitor for additive immunosuppression.

Frequently Asked Questions

Mometasonfuroat Aristo Pharma contains mometasone furoate, a nasal corticosteroid indicated for the treatment of allergic rhinitis and nasal polyps. It helps reduce nasal inflammation, congestion, itching and sneezing associated with these conditions.

Mometasone furoate binds to glucocorticoid receptors in nasal epithelial cells, altering gene transcription to suppress pro‑inflammatory cytokines, chemokines and adhesion molecules. This reduces vascular permeability, edema and inflammatory cell infiltration, leading to relief of nasal symptoms.

The appropriate dose and duration of Mometasonfuroat Aristo Pharma are determined by the prescribing healthcare professional based on the patient’s condition, age and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing women.

To request Mometasonfuroat Aristo Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency nasal corticosteroid with a favorable safety profile when used at recommended doses. Compared with lower‑potency agents such as fluticasone, it may achieve similar symptom control with a lower daily dose, but choice of therapy should be individualized by the prescriber.

Store the nasal spray at room temperature, below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

The product is a nasal spray. The patient should gently blow the nose, insert the tip into one nostril, and spray the prescribed number of sprays while breathing in gently. The same procedure is repeated in the other nostril if directed by the prescriber.

Serious but rare risks include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression when used at high doses for prolonged periods. Patients should report any unusual symptoms promptly to their healthcare provider.

Patients with a known hypersensitivity to mometasone furoate or any component of the formulation should avoid using the product. It is also contraindicated in the presence of active untreated nasal infections until the infection has been resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate Ph. Eur.

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT